Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma.
Bassot A, Dragic H, Haddad SA, Moindrot L, Odouard S, Corlazzoli F, Marinari E, Bomane A, Brassens A, Marteyn A, Hibaoui Y, Petty TJ, Chalabi-Dchar M, Larrouquere L, Zdobnov EM, Legrand N, Tamburini J, Lincet H, Castets M, Yebra M, Migliorini D, Dutoit V, Walker PR, Preynat-Seauve O, Dietrich PY, Cosset É. Bassot A, et al. Among authors: migliorini d. Cell Death Dis. 2023 Sep 25;14(9):630. doi: 10.1038/s41419-023-06117-z. Cell Death Dis. 2023. PMID: 37749143 Free PMC article.
Checkpoint Blockade Reverses Anergy in IL-13Rα2 Humanized scFv-Based CAR T Cells to Treat Murine and Canine Gliomas.
Yin Y, Boesteanu AC, Binder ZA, Xu C, Reid RA, Rodriguez JL, Cook DR, Thokala R, Blouch K, McGettigan-Croce B, Zhang L, Konradt C, Cogdill AP, Panjwani MK, Jiang S, Migliorini D, Dahmane N, Posey AD Jr, June CH, Mason NJ, Lin Z, O'Rourke DM, Johnson LA. Yin Y, et al. Among authors: migliorini d. Mol Ther Oncolytics. 2018 Aug 28;11:20-38. doi: 10.1016/j.omto.2018.08.002. eCollection 2018 Dec 21. Mol Ther Oncolytics. 2018. PMID: 30306125 Free PMC article.
Diagnostic Accuracy of PET/CT or PET/MRI Using PSMA-Targeting Radiopharmaceuticals in High-Grade Gliomas: A Systematic Review and a Bivariate Meta-Analysis.
Muoio B, Albano D, Dondi F, Bertagna F, Garibotto V, Kunikowska J, Piccardo A, Annunziata S, Espeli V, Migliorini D, Treglia G. Muoio B, et al. Among authors: migliorini d. Diagnostics (Basel). 2022 Jul 8;12(7):1665. doi: 10.3390/diagnostics12071665. Diagnostics (Basel). 2022. PMID: 35885569 Free PMC article. Review.
[Multidisciplinar approach to the management of gliomas].
Moura B, Migliorini D, Bourhis J, Daniel R, Levivier M, Hottinger AF. Moura B, et al. Among authors: migliorini d. Rev Med Suisse. 2016 Apr 27;12(516):821-5. Rev Med Suisse. 2016. PMID: 27281939 French.
[Cerebral lymphoma: a classic presentation?].
Nemitz I, Migliorini D, Dietrich PY. Nemitz I, et al. Among authors: migliorini d. Rev Med Suisse. 2015 Feb 4;11(460):371-3. Rev Med Suisse. 2015. PMID: 25854049 French. No abstract available.
The CD40/CD40L axis in glioma progression and therapy.
Walker PR, Migliorini D. Walker PR, et al. Among authors: migliorini d. Neuro Oncol. 2015 Nov;17(11):1428-30. doi: 10.1093/neuonc/nov138. Epub 2015 Jul 22. Neuro Oncol. 2015. PMID: 26206773 Free PMC article. No abstract available.
Immunotherapy of Brain Tumors.
Dutoit V, Migliorini D, Walker PR, Dietrich PY. Dutoit V, et al. Among authors: migliorini d. Prog Tumor Res. 2015;42:11-21. doi: 10.1159/000436986. Epub 2015 Sep 4. Prog Tumor Res. 2015. PMID: 26376741 Review.
104 results